- Home
- BBIO vs FHN Comparison
BBIO vs FHN Comparison
Compare BBIO & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- FHN
- Stock Information
- Founded
- BBIO 2015
- FHN 1864
- Country
- BBIO United States
- FHN United States
- Employees
- BBIO N/A
- FHN N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- FHN Major Banks
- Sector
- BBIO Health Care
- FHN Finance
- Exchange
- BBIO Nasdaq
- FHN Nasdaq
- Market Cap
- BBIO 10.4B
- FHN 11.0B
- IPO Year
- BBIO 2019
- FHN N/A
- Fundamental
- Price
- BBIO $66.62
- FHN $20.72
- Analyst Decision
- BBIO Strong Buy
- FHN Buy
- Analyst Count
- BBIO 16
- FHN 20
- Target Price
- BBIO $65.88
- FHN $24.10
- AVG Volume (30 Days)
- BBIO 2.2M
- FHN 17.4M
- Earning Date
- BBIO 10-29-2025
- FHN 10-15-2025
- Dividend Yield
- BBIO N/A
- FHN 2.85%
- EPS Growth
- BBIO N/A
- FHN 19.36
- EPS
- BBIO N/A
- FHN 1.64
- Revenue
- BBIO $235,812,000.00
- FHN $3,185,000,000.00
- Revenue This Year
- BBIO $115.12
- FHN $12.50
- Revenue Next Year
- BBIO $65.29
- FHN $2.81
- P/E Ratio
- BBIO N/A
- FHN $12.82
- Revenue Growth
- BBIO 7.62
- FHN 3.75
- 52 Week Low
- BBIO $21.72
- FHN $15.19
- 52 Week High
- BBIO $65.00
- FHN $23.70
- Technical
- Relative Strength Index (RSI)
- BBIO 77.10
- FHN 41.13
- Support Level
- BBIO $52.75
- FHN $20.54
- Resistance Level
- BBIO $65.00
- FHN $21.43
- Average True Range (ATR)
- BBIO 2.34
- FHN 0.79
- MACD
- BBIO 1.00
- FHN -0.04
- Stochastic Oscillator
- BBIO 80.66
- FHN 26.92
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.